Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer.

Kasimir-Bauer, Sabine; Keup, Corinna; Hoffmann, Oliver; Hauch, Siegfried; Kimmig, Rainer; Bittner, Ann-Kathrin

Kasimir-Bauer, Sabine; Keup, Corinna; Hoffmann, Oliver; Hauch, Siegfried; Kimmig, Rainer; Bittner, Ann-Kathrin.

Afiliação

Kasimir-Bauer S; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany.
Keup C; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany.
Hoffmann O; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany.
Hauch S; QIAGEN GmbH, Hilden, Germany.
Kimmig R; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany.
Bittner AK; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany.

Front Oncol ; 10: 1658, 2020.

Article em En | MEDLINE | ID: mdl-33014830

Palavras-chave

PSMA; androgen receptor; androgen receptor splice variant seven; circulating tumor cells; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google